In this podcast, Tawandra Rowell-Cunsolo, PhD, discusses her recent study, which identified 4 barriers to optimal antiretroviral therapy adherence among individuals with HIV who were formerly incarcerated,...
New research indicates that many women living with HIV may prefer a monthly long-acting injectable antiretroviral therapy, once FDA-approved, instead of daily pills. Consultant360 discussed these findings...
Davide De Francesco, from University College London, answers our questions about his study on whether people with HIV experience greater age advancement than patients without HIV.
Consultant360 spoke with Keith Horvath, PhD, about his study, which indicated that technology-assisted HIV testing interventions could serve as a key strategy in reaching national and global targets for HIV...
The incidence of sexually transmitted infections has increased significantly among individuals with HIV. Carole Khaw, MD, from the Royal Adelaide Hospital answers our questions about proactively managing...
Patients with psoriasis and HIV comprise a unique subgroup that requires special consideration for treatment due to complications and comorbidities associated with both diseases, according to Wilson Liao,...
In this Editorial, Shobha Swaminathan, MD, writes about the shift from desperation and fear regarding HIV/AIDS in the 1980s to optimism and hope today.
In this podcast, Evan Brickner and Trini Mathew, MD, MPH, discuss their latest research paper on evaluating for alcohol use disorder among patients with HIV in their primary care clinic, how other...
In this podcast, Brooke Nichols, PhD, answers our questions about her team's novel and pragmatic metric to evaluate and compare pre-exposure prophylaxis program effectiveness using routine implementation...
Kathleen Ryan, PhD, answered our questions about her study, which indicated that rapid scale-up of PrEP was possible without the consequence of reduced HIV testing among Australian gay, bisexual, and other...
